FGF-13 Double Nickase Plasmid (h): sc-404979-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- FGF-13 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- FGF-13 Double Nickase Plasmid (h) and FGF-13 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting FGF13. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
FGF-13 Double Nickase Plasmid (h) | sc-404979-NIC | 20 µg | $410.00 | |||
FGF-13 Double Nickase Plasmid (h2) | sc-404979-NIC-2 | 20 µg | $410.00 |
FGF13 encodes fibroblast growth factor 13 (FGF-13), an intracellular member of the FGF family that functions independently of canonical FGF receptor signaling. FGF-13 interacts with voltage-gated sodium channels and the microtubule cytoskeleton to regulate neuronal excitability, axonal development, and activity-dependent signaling. Through these roles, it contributes to processes such as cytoskeletal organization and ion channel trafficking that shape synaptic function and network behavior. Dysregulated FGF13 expression or function has been linked in research settings to neurodevelopmental and neuropsychiatric phenotypes, supporting its relevance for mechanistic studies of nervous system biology.
FGF-13 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the FGF13 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within FGF13. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt FGF13 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of FGF13-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.